Results 211 to 220 of about 687,004 (308)

EEG Time-Frequency Clustering Reveals Spectral Signatures of Glutamatergic and Cholinergic Activities and Their Interrelations. [PDF]

Biomedicines
Vorobyov V, Deev A.
europepmc   +1 more source

Modulation of Master Transcription Factor Expression of Nile Tilapia Leukocytes via Cholinergic Pathways. [PDF]

Int J Mol Sci
Girón-Pérez MI, Ramírez-Ibarra KM, Covantes-Rosales CE, Girón-Pérez DA, Razura-Carmona FF, Contis-Montes de Oca A, Morales-Montor J, Pavón L, Toledo-Ibarra GA.   +8 more
europepmc   +1 more source

Muscarinic Antagonist Antidepressants Lacking Cognitive Deficits

American Journal of Pharmaceutical Education
Chad Johnson, Brian Kangas, Emily Jutkiewicz, Andy Coop   +3 more
openaire   +1 more source

Risk of Hospitalized Cardiovascular Events Associated with LAMA/LABA/ICS FDC versus LABA/ICS FDC in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Sun SH, Lu MJ, Chen CY, Tsai NH, Pan SW, Dong YH.   +5 more
europepmc   +1 more source

Xanomeline-Trospium Chloride as a New Paradigm in the Treatment of Schizophrenia Through Muscarinic Modulation: A Renewed Hope in Psychiatric Care. [PDF]

Cureus
Raza M, Kaur J.
europepmc   +1 more source

Ten Years in a Pediatric Center: Detecting Esophageal Pathology and Symptoms in Aerodigestive Patients. [PDF]

Gastro Hep Adv
Ballenger K, Kewalramani A, Bernard L, Driscoll K, Waddell J, Lasso-Pirot A, Hong J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Long-acting muscarinic antagonists

Expert Review of Clinical Pharmacology, 2015
Chronic obstructive pulmonary disease (COPD) is a major cause of death and disability worldwide. Inhaled bronchodilators are the mainstay of COPD pharmacological treatment. Long-acting muscarinic antagonists (LAMAs) are a major class of inhaled bronchodilators.
A. Melani
semanticscholar   +3 more sources

Muscarinic Receptor Antagonists.

Handbook of Experimental Pharmacology, 2016
Parasympathetic activity is increased in patients with chronic obstructive pulmonary disease (COPD) and asthma and appears to be the major reversible component of airway obstruction. Therefore, treatment with muscarinic receptor antagonists is an effective bronchodilator therapy in COPD and also in asthmatic patients.
M. Matera, M. Cazzola
semanticscholar   +3 more sources